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Skin lesio.ns o.flicheno.id amylo.ido.sis and macular amylo.ido.-
sis were immuno.histochemically investigated using five 
mo.no.clo.nal antibo.dies against basement membrane zo.ne 
(BMZ) compo.nents. A hemidesmoso.mal component did not 
co.ntribute to. amyloid deposits, but co.mponents of the lamina 
densa and anchoring fibrils were associated with amylo.id 
depo.sits in the uppermo.st dermis. Immuno.electron micro.s-
copy revealed that these BMZ components were not only 
aggregated in the BMZ and dermis, but were also involved in 
the individual amylo.id islets. The lamina densa was disrupted 
A myloid is a generic term that defines an amorphous homogeneous eosinophilic material that shows char-acteristic green birefringence on Congo-red staining when viewed under polarized light [1]. Electron mi-croscopy demonstrates that amyloid bodies are com-
posed of7.5 to 10 nm thick, straight, nonbranching fibrils, aggre-
gated in an irregular, loose meshwork [2]. Although amyloid 
deposits in different clinicopathologic types of amyloidosis have 
histologically and morphologically identical properties, it has be-
come apparent that there are several distinguishable mechanisms in 
the accumulation of amyloid substance in the tissues of amyloidoses. 
A partly degraded monoclonal immunoglobulin-light chain pro-
duced by the plasma cells is the source of amyloid substance in 
primary systemic and myeloma-associated amyloidoses [1,3]. Amy-
loid substance in secondary systemic amyloidosis and familial amy-
loid polyneuropathy is considered to originate from an acute phase-
reaction plasma apolipoprotein [4] and prealbumin [5], respectively. 
On the other hand, it is probable that in localized amyloidosis, the 
amyloid deposits originate from proteins synthesized in the tissues 
associated with such deposition. For example, amyloid in calci-
tonin-producing medullary carcinoma of the thyroid is thought to 
be derived from procalcitonin, the precursor of calcitonin [6]. The 
islet amyloid polypeptide, the putative precursor of the amyloid 
deposits in the islets of Langerhans in the diabetic pancreas, is pro-
duced in the secretory granules of islet p-cells [7]. 
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in the interface areas just above the amylo.id depo.sits, where 
cytoplasm of the basal cells directly faced the aggregate of 
amylo.id filaments. Aggregates o.f so.me BMZ co.mpo.nents 
were continuous to the amyloid islets from the lamina densa 
area. These findings suggest that a lamina densa malforma-
tion is involved in amylo.id productio.n in the interface of the 
BMZ, and suppo.rt the secretio.n theory rather than the fibril-
lar bo.dy theo.ry of amyloidogenesis in these types o.f primary 
localized cutaneous amyloidosis.] Invest DermatoI99:12-18, 
1992 
In primary localized cutaneous amyloidosis (PLCA), which in-
cludes lichenoid amyloidosis (LA), macular amyloidosis (MA), bi-
phasic amyloidosis (combined type of lichenoid and macular erup-
tions), and nodular amyloidosis, amino acid sequence analysis 
demonstrated that the amyloid fibril protein of the nodular type has 
homology with the immunoglobulin-light chain [8 -10]. Thus, the 
amyloid of this type ofPLCA seems to be derived from the immuno-
globulin-light chain. Although it has been generally believed that 
the epidermal cells are closely related to the deposition of amyloid 
substance in lichenoid and macular types of PLCA [11-13], how 
the amyloid is produced in the skin remains controversial. Intensive 
observations ofPLCA skin lesions by Hashimoto and his colleagues 
using electron microscopy and immunohistochemistry demon-
strated the fibrillar degeneration of epidermal cells and consequent 
dropping off of the fibrillar bodies into the dermis as the origin of 
amyloid in LA and MA [14-18]. They speculated that the further 
modification of the fibrillar bodies by histiocytes and/or fibroblasts 
is the cause of amyloidogenesis in these types (fibrillar body theory). 
However, it is true that the skin lesions of lichen planus and 
discoid lupus erythematosus, in which fibrillar degeneration of epi-
dermal cells is frequently seen [19,20], are rarely accompanied by 
amyloid deposits. Furthermore, the basic biochemical structure of 
keratin filaments is that of the a-helical chain, whereas that of 
amyloid is a p-pleated sheet, which is why amyloid presents bire-
fringence on Congo-red staining [1]. The former of these two con-
tradictions is postulated by the presence of specific immunologic 
tolerance to necrotic keratin masses in LA and MA, whereas in 
lichen planus and discoid lupus erythematosus, an inflammatory 
response ensures removal of fibrillar bodies and prevents amyloid 
deposition [21-23]. However, the latter contradiction still remains 
to be elucidated. 
Another hypothesis concerning histogenesis in these two types of 
PLCA is that the amyloid is produced in the interface of the epider-
mis and dermis by living basal keratinocytes, which produce the 
precursor of amyloid due to disturbed keratin metabolism (secretion 
theory) [24-26]. Supporting this theory is the close relationship 
between dissociated lamina densa-like material and amyloid depos-
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its [27,28]. Specifically, malformed lamina densa and anchoring 
fibnls are present within amyloid islets detectable just beneath the 
basal cells. In order to clarify the involvement of lamina densa 
malformation in the histogenesis of LA and MA, we immunohisto-
c.hemically studied the epidermal-dermal interface of the skin le-
Sions of these conditions using antibodies against several basement 
membrane zone (BMZ) components of the skin. 
MATERIALS AND METHODS 
Tissue Preparation Punch-biopsied samples from skin lesions of 
LA (five patients), MA (two patients), and biphasic amyloidosis 
(three patients; both types of eruptions were examined) were cryo-
protected by soaking in a phosphate-buffered saline (PBS) series 
supplemented with 10% glycerine and 10-20% sucrose for 2 h 
each step, embedded in optimum cutting temperature compound, 
Tlssue-Tek (Miles, Naperville, IL) containing 8% glycerin and 
16% sucrose, and frozen with acetone-carbon dioxide as previously 
described [29]. 
Antibodies The following five mouse monoclonal antibodies 
aga~nst BMZ components of human skin and a polyclonal antibody 
~gall1st the amyloid-P component were used for immunohistochem-
IStry: 1-2B7B monoclonal antibody [29] recognizes a 120-kDa poly-
peptide component of the hemidesmosome and the hemidesmo-
some-like adhesion junction structure between the endothelial cells 
and the surrounding lamina densa of capillary vessels. Anti-human 
type IV collagen monoclonal antibody was commercially obtained 
(Dakopatts, Glostrup, Denmark). LDA-l monoclonal antibody [30] 
reac.ts to a noncollagenous component of the lamina densa and sub-
lamll1a densa region of the skin. LH 7: 2 monoclonal antibody [31] 
recognizes a domain of type VII collagen, which is known to be a 
m~or polypeptide component of anchoring fibrils. Anti-human la-
~llnll1.monoclonal antibody (4C7 jB4) was produced by immuniz-
ll1g mice with human placental extract [32]. The polyclonal rabbit 
antibody against the amyloid-P component was commercially ob-
tall1ed (Dakopatts) . 
Inununofluorescence Staining Six serially cut 6-,um - thick 
c~osections were mounted on albuminized glass slides and air 
dned. Each section was first incubated with 1-2B7B monoclonal 
antibody (5,ugjml), anti-type IV collagen antibody (X 100 dilu-
tIOn), LDA-l monoclonal antibody (10 ,ugjml), LH 7: 2 monoclo-ral .antibody (X 40 dilution of culture supernatant), anti-~uman 
amlnln monoclonal antibody (X8000 dilution of ascites flUid), or 
a~tl-amyloid P component antibody (X 5000 dilution) overnight at 
4 C. After three washes with PBS, the sections incubated with 
monoclonal antibodies were reacted with biotinylated anti-mouse 
IgG (Vectastain kit, Vector Laboratories, Burlingame, CA) for 2 h 
at room temperature. The sections incubated with anti-amyloid P 
c(~mpone~t antibody were reacted with biotinylated anti-rabbit IgG 
ectastall1 kit) under the same staining conditions. The sections 
Were washed with PBS and incubated with FITC-labeled avidin ~~ 1000 dilution, Vector Laboratories) for 2 h at room temperature. 
ter final washes with PBS each slide was mounted under a co-
verslip with 90% glycerin a~d examined under an epifluorescence 
microscope (Nikon, Tokyo, Japan). The negative control study 
used anti-trinitrophenol (TNP) monoclonal antibody [33] and nor-
mal rabbit serum. 
Ifununoelectron Microscopy The ultrastructural localization 
o t~e BMZ components was determined by the avidin-biotin-per-~lCl base-complex method applied to immunoelectron microscol?Y' 
1~2 nef, 6-,um-thick serial cryosections were incubated wI~h 
B7B, anti-type IV, LDA-l LH 7: 2, or anti-human lamll1ln ~onoclonal antibody, then with biotinylated anti-mouse IgG, at 
i e same concentration and under the same conditions as those for r~munofluorescence staining. After PBS washes, the sections were ki:)~ed with soluble avidin-biotin-peroxidase-complex (Vectastain 
tio or 2 h at room temperature. After washes With PBS, the sec-
ns Were treated with 1 % glutaraldehyde solution in PBS for 
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5 min, then serially incubated with 0.2 mg/ml diaminobenzidine 
(DAB) and a mixture of DAB and 0.005% hydrogen peroxide. 
These sections were post fixed with 1 % osmium tetroxide, dehy-
drated with a graded alcohol series, and embedded in Spurr's resin, 
as previously described [29]. Ultrathin sections were counterstained 
with Reynold's lead citrate and examined under an H500 electron 
microscope (Hitachi, Tokyo, Japan) . As a negative control, anti-
TNP monoclonal antibody was substituted for the monoclonal anti-
bodies. 
RESULTS 
Immunofluorescence microscopy revealed deposits of the BMZ 
components in the same areas as the amyloid aggregates, as well as 
along the BMZ of the epidermal-dermal junction and dermal vascu-
lature. Although 1-2B7B monoclonal antibody retained only linear 
staining along the BMZ, anti-type IV and VII collagen monoclonal 
antibodies showed thick granular deposits in the areas of amyloid 
aggregates. Immunofluorescence ofLDA-l and anti-Iaminin mono-
clonal antibodies showed rather fine granular deposits in the dermis. 
These staining patterns were seen in all of the samples from LA, 
including biphasic type (Fig 1). The MA sections contained a lesser 
amount of, but virtually the same proportions ofBMZ components 
in the dermis. 
Sections and areas estimated by immunofluorescence to include 
masses of amyloid islets were selected and intensively investigated 
Figure 1. Immunofluorescence micrographs of serial sections from a skin 
lesion of LA stained with anti-amyloid P component antibody (A), 1-2B7B 
(B) , anti-type IV collagen (C), LDA-l (D), LH 7: 2 (B), and anti-laminin 
(F) monoclonal antibodies. (A) Amyloid bodies (opw arrows) are aggregated 
beneath the epidermis (Ep) . (B) 1-2B7B monoclonal antibody stains the 
BMZ (arrow) of the epidermis (Ep) and capillary vessels (arrowheads) of the 
dermis (De). (C,D) Immunofluorescence of anti-type IV collgen and LDA-
1 monoclonal antibodies indicated the presence oflamina densa components 
granularly distributed in the uppermost dermis (ope" arrows) as well as along 
the BMZ (arrow) and capillary vessels (arrowheads) . (B) Immunofluores-
cence of LH 7 : 2 monoclonal antibody reveals granularly thick distribution 
of type VII collagen (ope" arrows) in the uppermost dermis (De) and along 
the BMZ (arrow) of the epidermis. (F) A little amount of laminin is de-
scended down into the uppermost dermis (ope" arrows) from the BMZ 
(arrow) of the epidermis. Arrowheads, capillary vessels. Magnification X 350. 
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Figure 2. (A) A low-powered immunoelectron micrograph of LA reacted with 1-2B7B monoclonal antibody. Reaction products are distributed along the 
BMZ (arrows) of the epidermis (Ep). No reaction products are detectable among the amyloid islets (asterisks). Bar, 10 J1.m. (B) An enlarged photograph of the 
rectangular area of A shows that the distribution of reaction products beneath the hemidesmosomes (arrow) is disrupted at the area (betweetz arrowheads) where 
tonofilaments (Tf) of the basal cell are directly apposed to the aggregate of amyloid filaments (Amy) without interposing lamina densa. Bar, 1 J1.m. 
by immunoelectron microscopy. The reaction products of 1-2B7B 
monoclonal antibody were distributed along the dermal surface of 
the basal cells, but were not associated with the amyloid islets in the 
dermis. In the areas where the amyloid islets were close to the basal 
cells, the distribution of 1-2B7B immunoreactants was partly dis-
continuous, and neither the lamina densa nor hemidesmosomes was 
detectable in these areas. The tonofilaments of the basal cells were 
directly apposed to the aggregates of amyloid filaments (Fig 2). The 
reaction products of anti-type IV collagen monoclonal antibody 
were irregularly dense in the lamina densa and sublamina densa 
region, and were also seen patchily or diffusely within individual 
amyloid islets. The aggregates of immunoreactants of anti-type IV 
collagen appeared to be continuously distributed from the lamina 
densa or the sublamina densa region to amyloid islets in the upper-
most dermis (Fig 3). Immunoelectron microscopy ofLDA-l mono-
clonal antibody staining revealed fine granular distribution of the 
immunoreactants in the small amyloid islets and in the peripheral 
areas of large amyloid islets, as well as in the lamina densa and 
sublamina densa region. In portions where the immunoreactants 
were irregularly distributed beneath the basal celis, the lamina densa 
was disrupted, dissociated from the basal cell, and continuous to 
aggregates of amyloid filaments (Fig 4). The distribution pattern of 
the reaction products of LH 7: 2 monoclonal antibody was coarsely 
granular in those areas within the sublamina densa region where 
lamina densa-like amorphous material and amyloid filaments irregu-
larly coexisted. Patchy aggregates of immunoreactants were also 
noted within individual amyloid islets. Some basal cells contained 
Figure 3. (A) A low-powered immunoelectron micrograph of LA stained 
with anti-type IV collagen antibody shows patchily or diffusely distributed 
aggregates of reaction products among the amyloid islets (asterisks) and the 
regular and irregular arrangement of reaction products along the BMZ 
(arrows) of the epidermis (Ep). Some arrays of reaction products (double 
arrows) indicate the reaction along the dissociated lamina densa. Bar, 10 J1.m. 
(B) An enlarged photograph of the rectangular area of A shows dislocated 
lamina densa materials (LD) containing type IV collagen continuing to the 
amyloid islet (Amy) . In some areas, the basal cell faces amorphous material 
(arrows) that lacks the epitope for this monoclonal antibody. Bar, 1 J1.m. 
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Figure 4. (A) A low-powered view of immunoelectron microscopy of LA stained with LDA-1 monoclonal antibody shows reaction products distributed in 
the small amyloid islets (dou ble arrows), peripheral areas oflarge amyloid islets (asterisks), and along the BMZ (arrows) of the epidermis (Ep). The distribution of 
reaction products are absent in some areas of the BMZ (arrowhead). Bar, 10 }1m. (B) An enlarged photograph of the rectangular area of A shows that the 
LDA-1_ positive lamina densa (arrow) shifts to the aggregate of amyloid filaments (Amy), and that the loosened tonofilaments (Tf) protrude into the dennis. 
Bar, 1 }1m. 
type VII collagen-reactive immunodeposits within the cytoplasm. ~t seemed that perinuclear space and enlarged endoplasmic reticu-
Urn contamed the immunoreactants (Figs 5 - 7). Immunoreactants 
th the anti-laminin monoclonal antibody were diffusely involved in 
~. e amyloid islets. The distribution of laminin along the BMZ was 
llsrupted along portions of the epidermal-dermal junction where b le lamina densa was absent. In such areas, tonofilaments of the 
asal cells seemed to directly face the amyloid islets (Fig 8). There 
we:e no histiocytes or fibroblasts phagocytizing the amyloid depos-
Its II1 the areas where aggregates of the BMZ components coexisted 
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with amyloid deposits. Amyloid islets in the deeper dermis con-
tained smaller quantities of BMZ components. 
DISCUSSION 
The presence of a lamina densa-like substance and anchoring fibrils 
within the amyloid deposits in the skin lesions of PLCA was first 
demonstrated by Kumakiri et al [27]. who detected the BMZ sub-
stance in the dermis not only with electron microscopy but also with 
immunohistochemistry using a bullous pemphigoid serum, and 
concluded that apoptotic keratinocytes of the epidermis brought 
p' a~~:~~ 5~ Immunoelectron microscopic scanning view of the uppermost dermis (D~) and BMZ of the epidermis (Ep) of LA stained with LH 7 : 2 monoclonal 
amon \ hows reaction products contll1uously dlstnbuted along the BMZ at the left Side of the field (arrows) . ReactIOn products are along granularly distributed 
g t e amylOid Islets (asterisks) and in the epidermal cells (arrowheads). Bar, 10 }1m. 
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Figure 6. (A) In this low-powered view of the left rectangular area of Fig 5, irregularly thick distribution of reaction products (double arrows) just beneath the 
epidermis (Ep) and among amyloid islets (asterisks) are seen, as well as along normally looking lamina densa (arrows). Bar, 10 j.lm. (B) An enlarged photograph 
of the rectangular area of A shows reaction products distributed along the dissociated lamina densa-like material (LD) and aggregates of amyloid filaments 
(Amy). In the aggregate of reaction products, a tonofibril-like bundle of filaments is seen (arrow). Bar, 1 j.lm. 
down the lamina densa and fine fibrous components attached to it 
when these cells dropped to the papillary dermis and became the 
source of amyloid. Lee et al [34] demonstrated aggregates of an-
choring fibrils in amyloid islets associated with trichoepithelioma, 
supporting the fibrillar b.ody theory. However, it is rather difficult 
to imagine how the degenerating keratinocytes involve the compo-
nents of the lamina dens a and anchoring fibrils inside themselves or 
how, once completed, the lamina densa is drawn down into the 
dermis with a dropping-off of fibrillar bodies. Furthermore, the 
immunohistochemical study using a bullous pemphigoid serum to 
detect the BMZ substance in aggregates of amyloid [27] has two 
problems. The first is that the bullous pemphigoid antigen is a 
component of the hemidesmosome [35 - 38), not of the lamina 
densa. The second is that, because the amyloid deposits carry in vivo 
bound immunoglobulins themselves [39 -41), it is hard to deter-
mine whether the labeled anti-human IgG antibody reacted to ap-
plied bullous pemphigoid serum, or to in vivo bound IgG. 
The generally accepted fibrillar body theory of the amyloidogen-
esis of PLCA is virtually based upon ultrastructural findings that the 
amyloid substance coexists with the filamentous body, sometimes 
known as the colloid-amyloid body [14-16,42] and immunohisto-
chemical findings that amyloid has common antigenicities with 
keratin filaments [17,18J. The finding that histiocytes and fibro-
blasts contain amyloid bodies in their cytoplasm [43] also supports 
this theory. The key point of this theory is that the fibrillar bodies, 
namely the aggregated cytoskeleton of the keratinocytes, suppos-
edly composed of keratin, are phagocytized by the histiocytes and/ 
or fibroblasts, converted to amyloid substance, and discharged out-
side of the cytoplasm. Although the amyloid substance in LA and 
MA is not yet biochemically characterized, it is natural to think that 
the amyloid in these types, which shows also birefringence on 
Congo-red staining, is mainly composed of p-pleated sheets similar 
to other types of amyloid [1]. How the histiocyte and/or fibroblast 
converts the a-chain of keratin to the p-pleated sheet of amyloid has 
not been substantially proven. Even if this is the case, it is unlikely 
that only the fibrillar body is digested and converted to amyloid, 
Figure 7. (A) Enlarged photograph of the central rectangular area of Fig 5 
reveals aggregates of reaction products in the perinuclear area (arrowheads) of 
a basal cell (Be) and among aggregated amyloid-like filaments (Amy) just 
outside of the cell. It seems that the distribution of the reaction products is 
continuous (arrow) from the perinuclear area to the extracellular area. Bar, 
1 j.lm. (B) An enlarged photograph of the right rectangular area of Fig 5 
shows a mixture of the reaction products (arrows) in the amyloid islet (Amy) 
and patchy distribution of reaction products (arrowheads) in the basal cell 
(Be). The lamina densa (double arrows) is rarely seen. Bar, 1 j.lm. 
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Figure 8. (A) A low-powered immunoelectron micrograph of LA stained with anti-laminin monoclonal antibody. Reaction products are seen along the 
BMZ (arrows) of the epidermis (Ep), in the uppermost dermis (double arrows) and diffusely in the amyloid islets (asterisks) . Bar, 10 j.l.m. (B) An enlarged 
p( hotograph of the rectangular area of A shows disruption of the lamina densa (arrow) and apposition of aggregated amyloid filaments (Amy) and tonofibrils 
Tf) of the basal cell Bar, 1 j.l.m. 
whereas the dissociated lamina densa and anchoring fibrils remain 
unchanged, associating with the amyloid. 
Another hypothesis for amyloidogenesis of PLeA, excepting 
hodular amyloidosis, is the secretion theory proposed by Yanagi-
. ara et al [24,25]. Their theory states that amyloid is produced in the 
~nterfa.ce .of the epidermis and dermis, and that the precursor of the 
I rnylOid IS possibly secreted from the basal cells. They reached this 
lypot~esis on the basis of electron microscopic findings that the 
arnylOid deposits just beneath the basal cells are small and directly 
~posed to the basal cells without interposition of the lamina densa. 
h esterrnark et al [26] postulated disturbed keratin metabolism in ~ e basal cells, which secrete the precursor of the amyloid in LA. 
trIguchi et al [28] electron microscopically examined skin lesions 
o a case ofbiphasic amyloidosis, and revealed the absence of normal 
structures of lamina densa and hemidesmosomes between the up-
pyrnost amyloid deposits and the basal cells, as well as the close 
re atlonship between dissociated lamina densa-like substance and ~rnYloid . They speculated that the amyloid in this case was pro-
uCI;d In the epidermal-dermal interface involving lamina densa 
rna forrnation. 
In this study, immunofluorescence and immunoelectron micros-
COpy revealed the rare contribution of a hemidesmosomal compo-
nent in the arnyloid deposits in LA and MA. However, four other 
c~rnpone~ts of epidermal BMZ were also involved in the aggregates 
o Itrnylold deposits but in a slightly different manner. Type IV ~~ff~gen, a major component of the lamina densa, was patchily and 
a h se1y Involved, and type VII collagen, a major component of 
Lnc .0r.Ing fibrils, was patchily involved in individual amyloid islets. 
d arnInIn, another major component of the lamina I ucida and lamina 
a ensa Was rather diffusely seen with amyloid islets . LDA-l antigen, 
p n?~ollagenous BMZ component [30]' was associated with the 
thrIF e;y of amyloid islets. This re-distribution of components of 
ex
e I a.mIna densa and sublamina densa region cannot be sufficiently 
la p .:tIned by the theory that dropping-off fibrillar bodies bring the B~~a densa into the dermis. Furthermore, some aggregates of the 
and h cornpone.nts seemed to be continuous from the lamina densa 
bas f e sublamma densa region to amyloid islets . In addition, some 
agga cells above amyloid aggregates demonstrated intracytoplasmic 
pertegaltes of type VII collagen that seemed to be retained in the 
buttuc rar area and endoplasmic reticulum. The continuous distri-
on 0 these BMZ components along the interface was disrupted 
in many areas where the cytoplasm of the basal cells directly faced 
the amyloid bodies. These findings suggest that lamina densa for-
mation is highly disturbed in the areas of amyloid deposition, and 
that individual amyloid islets may be closely related to the lamina 
densa malformation. We can conclude here that, though these find-
ings do not directly certify the secretion theory of amyloidogenesis 
in LA and MA, they are more appropriately explained by the secre-
tion theory than by the apoptotic fibrillar body theory. 
The secretion theory can explain several other characteristic fea-
tures of the histology of LA and MA. The intracytoplasmic aggre-
gate of the amyloid filaments occasionally seen in the keratinocytes 
[28,44] should represent the retention of amyloid that was produced 
but not discharged outside of the basal cells. The presence of col-
loid-amyloid body [14], or collagen fibrils woven among the amy-
loid fibrils [45] should result from the involvement of fibrill ar 
bodies or collagen fibrils within the amyloid secretion by the basal 
cells . The reason the amyloid islets in the mid-dermis are large, 
round or oval, and well demarcated,_whereas the uppermost amy-
loid islets are small, irregularly shaped, and have a fuzzy outline, 
may be that amyloid is produced beneath the basal cells, then repeat-
edly enclosed, treated, and packaged by cytoplasmic projections of 
migrating histiocytes and fibroblasts, thus changing its size and 
shape. The amyloid bodies enclosed in the cytoplasm of fibroblasts 
and histiocytes should not be undergoing digestion, but merely 
packaging. Routine histologic preparation of the skin lesions of LA 
frequently shows cleavage at the epidermal-dermal interface where 
amyloid is massively aggregated [46]. This should result from the 
fact that the epidermal-dermal interface is only incompletely 
integrated due to malformed hemidesmosome and lamina densa 
structures. 
Westermark et al [26] postulated two different histogenetic path-
ways in LA and MA: secretion in LA and via the filamentous body in 
MA. However, in our study there were no substantial differences in 
involvement of malformed lamina densa between LA and MA. In 
both LA and MA, amyloid substance is most likely produced in the 
interface of the epidermal-dermal junction by living basal cells ac-
companied by malformation of the lamina densa. 
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